Virginia Polytechnic Institute and State University
Blacksburg, Virginia, 24061, United States
Location status: Recruiting
Location contact
Benjamin Katz, PhD
CONTACT
Tae-Ho Lee, PhD
CONTACT
NCT Number: NCT05574634
A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. However, the underlying neurobiological pathophysiological changes in the brain that contribute to these declines are still largely unclear. The objective of this proposal is to investigate neural mechanisms of age-related attentional distractibility, focusing on the neural circuit initiated from the locus coeruleus (LC). In the current proposal, the investigators will test the hypothesis that the neural disconnectivity of LC with the salience network (SN) drives failures of ignoring distractors in older adults. The investigators will examine how LC-SN connectivity is associated with selective attention performance, and how improved LC-SN connectivity through a cognitive training program may lead to improved attentional performance.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Blacksburg, Virginia, 24061, United States
Location status: Recruiting
Benjamin Katz, PhD
CONTACT
Tae-Ho Lee, PhD
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion:
Exclusion:
An adaptive at-home tablet-based program that includes variants of the Flanker Task, the Stroop Task, and a Visual Tracking Task. Each session of practice will include up to ten minutes with each of these task types, and the tasks will increase in difficulty in a way that further taxes attention (such as through more distractors or more incongruent trials) as participant performance improves.
An adaptive, at-home tablet-based variant of the criterion task, that is, the selective attention/distraction task used during the scanning portion of the human participant portions of the study, that takes up to 25 minutes to complete each session.
Time frame: Scan before and after attentional practice (2 weeks between scans)
During this task, participants will be presented to with target place stimuli overlaid on nonexpressive faces) and be asked to identify categories of place images ('building' to 'house') selectively as soon as possible while ignoring overlapped faces. The investigators will also include place only images to measure participants' baseline neural activation when there is no distractor. Each image condition will be presented in a mixed event related design that includes 15 blocks for each condition as a function of image type (overlaid vs. place-only). The block order will be counterbalanced and each block will be separated by a 10-s blank screen.
Time frame: Scan before and after attentional practice (2 weeks between scans)
An fMRI measure of LC-SN connectivity
Contact information is provided by the study sponsor or research team.
Benjamin Katz, PhD
CONTACT
Tae-Ho Lee, PhD
CONTACT
Virginia Polytechnic Institute and State University
Other
Losing Specificity: the Role of the Locus Coeruleus in Age-related Distractibility
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06565169
Aging, Alzheimer Disease
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06501495
Aging, Alzheimer Disease
Paris, France
View Trial DetailsNCT05929703
Aging, Alzheimer Disease
Orange, California, United States
View Trial DetailsNCT05597124
Aging, Alzheimer Disease
Newark, New Jersey, United States
View Trial Details